- MISSING MH370: Pilot: I established contact with plane
- MISSING MH370: Fake passport bearers bought tickets together
- MISSING MH370: Debris near Tho Chu island not from MH370
- MISSING MH370: PM: Govt will review all protocols, upgrade KLIA's security
- MISSING MH370: Search in coastal areas
- UPDATE: Missing aircraft's pilot makes contact, rescue mission resumes
- Chong Wei is king again
- MISSING MH370: US dispatch two ships, aircraft to assist SAR operation
- MISSING MH370 : Businessman who cancels flight shocked over missing MAS plane
- MISSING MH370: Pix Gallery Day 2
- MISSING MH370: Thai police target 'passport ring' in vanished flight probe
- MISSING MH370: MAS to fly Chinese families to KL
- MISSING MH370: Radar showed missing plane may have turned back
- MISSING MH370: Chinese passengers family members arrive at KLIA
- MISSING MH370: Malaysia welcomes SAR assistance from other countries More
Ministry: Ranbaxy products in Malaysia safe to consume
KUALA LUMPUR: The Health Ministry assured the public that Ranbaxy products were safe from possible glass particle contamination.
Its deputy health minister Datuk Rosnah Abdul Rashid Shirlin said only the generic version of cholesterol busting drug Lipitor manufactured in India was affected.
“The public only have to worry if we import the product from India,” she told The New Straits Times yesterday after a confirmation with the National Pharmaceutical Control Bureau.
She said that according to the bureau, Ranbaxy products registered here were manufactured in its factory at Sungai Petani.
“Since it is manufactured locally, there is nothing to worry about,” she said, adding that Ranbaxy products here were not affected and need not be taken off the shelves.
It was earlier reported that Indian drug giant Ranbaxy ceased production of its generic version of cholesterol busting drug Lipitor until it probed the issue of “possible” glass particles in some consignments.
On Nov 9, the United States Food and Drug Administration (USFDA) informed customers in a statement on its website of a voluntary recall by Ranbaxy of some lots of its atorvastatin tablets, the generic version of Lipitor.
The medicine, packaged in bottles of 90 and 500 tablets, were recalled “due to possible contamination with very small glass particles similar to the size of a grain of sand”, the statement said.
It was understood that “Ranbaxy decided to stop making atorvastatin until the company has thoroughly investigated the cause of the contamination and remedied the problem,” the US agency said.
In the United States, the demand for the cholesterol lowering drug was a big boost to Ranbaxy’s sales.